IL1A and arteriosclerosis disorder: IL-1α released from damaged ECs drives the T helper 17 cell (Th17) responses that induce vessel arteriosclerosis and subsequent allograft rejection (6, 7), suggesting that ECs must be able to activate pro-IL-1α.